Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Why Praluent Could Be Blockbuster For Regeneron
Seeking Alpha
Tue, 07/7/15 - 12:31 pm
Praluent
Regeneron
What Is Beyond Vision-Loss Blockbuster For Regeneron?
Investors.com
Wed, 07/1/15 - 10:49 pm
Regeneron
Eylea
Praluent
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Amgen
Sanofi
Regeneron
Repatha
Praluent
PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
Isis Pharmaceuticals: Another Regeneron (Or Even Better) In The Making?
Seeking Alpha
Sun, 06/14/15 - 10:48 pm
Isis Pharmaceuticals
Regeneron
antisense
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Amgen
Regeneron
Sanofi
Repatha
Praluent
FDA
advisory panels
PCSK9 inhibitors
Why Regeneron’s down on a positive FDA recommendation
CNBC
Wed, 06/10/15 - 02:36 pm
Regeneron
Sanofi
Praluent
FDA
advisory panels
PCSK9 inhibitors
How The New Cholesterol Drugs From Amgen And Regeneron Could Still Be Blockbusters
Forbes
Wed, 06/10/15 - 09:08 am
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
BioPharma Dive
Tue, 06/9/15 - 06:33 pm
Sanofi
Regeneron
PCSK9 inhibitors
FDA
advisory panels
Praluent
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
PCSK9 inhibitors
FDA
advisory panels
Sanofi
Regeneron
Amgen
Repatha
Praluent
New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
FDA
advisory panels
Regeneron
AbbVie
Amgen
Repatha
alirocumab
PCSK9 inhibitors
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
FDA
advisory panels
Regeneron
Sanofi
Amgen
PCSK9 inhibitors
Praluent
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Yahoo/Reuters
Fri, 06/5/15 - 09:20 am
FDA
Sanofi
Regeneron
alirocumab
advisory panels
For The Pricing Of New Cholesterol Lowering PCSK-9 Drugs, Does Dose Size Matter?
Forbes
Mon, 06/1/15 - 12:16 pm
PCSK9 inhibitors
drug pricing
Amgen
Sanofi
Regeneron
Pfizer
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Valeant Pharmaceuticals
Actavis
Xifaxan
Orkambi
Vertex Pharmaceuticals
Regeneron
Sanofi
Amgen
Repatha
eluxadoline
Praluent
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Gilead Sciences
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
drug pricing
Repatha
Praluent
Fight over hot new cholesterol drugs may be won in milligrams
Yahoo/Reuters
Tue, 05/26/15 - 09:37 am
Amgen
Repatha
Regeneron
Sanofi
Praluent
The Most Loved Biotechs of Big Hedge Funds
24/7 Wall St
Sat, 05/23/15 - 11:41 am
biotech
Pharmacyclics
Gilead Sciences
Regeneron
Celgene
Amgen
A Beautiful Biotech Summer?
Barron's
Fri, 05/22/15 - 06:39 pm
biotech
Biogen
Alexion
Amgen
Celgene
Regeneron
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »